Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
$900
1-199 Kilogram
$800
200-499 Kilogram
$750
≥500 Kilogram
Product Description
Pterostilboglycoside capsules are a capsule-form supplement product containing pterostilbene-related glycoside ingredients. Because the term Pterostilboglycoside may refer to different glycosylated stilbene structures, responsible sourcing requires confirmation of the exact active compound identity, analytical specification, and regulatory suitability before use in finished dietary supplement products.
For supplement developers and private-label operators, capsule production depends on more than ingredient naming. Key considerations include confirmed chemical structure, assay method, raw material purity, capsule dosage format, excipient compatibility, stability, and compliance with the regulations of the target market.
Pterostilboglycoside capsules are oral solid dosage products formulated with a pterostilbene-related glycoside ingredient enclosed in a capsule shell. The ingredient category belongs to stilbene-related botanical compounds, which are commonly researched for their antioxidant properties and biological activity.
However, Pterostilboglycoside is not a universally standardized compound name in the same way as some established nutraceutical ingredients. The exact molecular structure, sugar moiety, CAS number, and specification should be confirmed through supplier documentation before formulation, labeling, or regulatory submission.
| Item | Specification |
|---|---|
| Product Name | Pterostilboglycoside Capsules |
| Product Category | Botanical stilbene-related glycoside capsule supplement |
| Dosage Form | Hard capsule or customized capsule format |
| Active Ingredient | Pterostilboglycoside or specified pterostilbene-related glycoside compound |
| CAS Number | Depends on the confirmed active compound structure |
| Molecular Formula | Depends on the confirmed glycoside structure |
| Molecular Weight | Calculated according to the verified molecular structure |
| Typical Appearance | Capsules containing white to off-white or light-colored powder, depending on formulation |
| Active Assay | Defined according to the raw material specification and validated analytical method |
| Testing Method | Typically HPLC-based assay with appropriate identity confirmation methods |
| Capsule Size | Common options include size 0, size 1, or customized capsule formats according to fill weight |
| Capsule Shell | Common options include gelatin or vegetarian capsule shells depending on market requirements |
| Fill Weight | Customized according to active ingredient concentration and formulation design |
| Excipients | Selected according to flowability, stability, capsule performance, and regulatory requirements |
| Shelf Life | Commonly 24 months when manufactured and stored under suitable conditions; final shelf life depends on stability evaluation |
| Storage | Store in a cool, dry place away from excessive heat, moisture, and direct sunlight |
| Packaging | Bottle, blister, or bulk packaging options according to market and customer requirements |
| Applications | Dietary supplement development, private label products, botanical ingredient formulations |
Pterostilboglycoside capsules are developed as botanical supplement products based on the characteristics of pterostilbene-related compounds. Research on stilbene derivatives has explored their antioxidant activity and biological properties.
These statements describe ingredient characteristics and research interest. They are not intended to represent disease treatment, prevention, or medical claims.
Pterostilboglycoside capsules may be considered for botanical supplement formulations where consumers seek plant-derived polyphenol ingredients. Product positioning should follow the applicable regulations of the target market and use only permitted structure-function or nutritional claims.
Capsule products provide a flexible format for brand owners developing customized supplement lines. Key development factors include ingredient identity, capsule size, dosage strategy, packaging format, labeling requirements, and stability testing.
Companies conducting ingredient evaluation may use capsule formulations as a finished dosage model for feasibility studies, market testing, and formulation development after confirming the raw material specification.
The most important sourcing factor for Pterostilboglycoside capsules is not capsule appearance but active ingredient verification. Since glycosylated stilbene compounds may vary by structure, buyers should establish identity and analytical criteria before comparing products.
| Selection Factor | Why It Matters | Buyer Check Point |
|---|---|---|
| Active compound identity | Different glycoside structures may have different chemical properties. | Confirm structure information, reference standard, and analytical identification. |
| Assay method | Reported potency depends on how the ingredient is measured. | Review HPLC method, reference standard, and calculation basis. |
| Capsule dosage | Determines consumer serving size and formulation positioning. | Match active content with target market requirements. |
| Stability profile | Botanical compounds may be affected by moisture, oxygen, and light. | Review packaging design and stability data. |
Pterostilboglycoside capsules can be supplied in different packaging formats depending on market requirements, including bottles, blister packs, and bulk packaging for further processing.
Packaging selection should consider moisture protection, transportation conditions, shelf-life requirements, and target sales channels. Custom packaging quantities, capsule colors, and labeling formats can be developed according to project needs.
OEM capsule development may include raw material sourcing, formulation adjustment, capsule filling, packaging design, and documentation support. Product specifications should define active ingredient identity, assay requirements, capsule parameters, and quality testing procedures before production.
Any dietary supplement application requires evaluation of ingredient legality, safety information, and applicable regulations in the intended market. Ingredient research interest does not automatically establish approval for use in all countries or product categories.
A suitable quality program for Pterostilboglycoside capsules may include:
Quality acceptance criteria should be established according to the intended market, formulation requirements, and applicable regulations rather than assumed universally.
Pterostilboglycoside capsules are developed as botanical supplement products containing a pterostilbene-related glycoside ingredient. They are typically positioned around plant-derived compound research and nutritional formulation concepts. Specific product claims must comply with the regulations of the target market.
No. Pterostilbene is a specific stilbene compound, while Pterostilboglycoside refers to a glycoside-related form. The exact chemical relationship depends on the confirmed molecular structure and should be verified through technical documentation.
Buyers should request a product specification sheet, batch COA, raw material identity information, analytical method details, stability information, and manufacturing documentation appropriate for the intended market and application.
Pterostilboglycoside capsules require careful ingredient verification, quality documentation, and formulation planning to support reliable supplement development. Confirming the active compound identity, analytical method, dosage format, and regulatory suitability helps buyers select an appropriate finished product.
Contact us today to request samples, a COA, technical documents, and a wholesale quotation.

Packaging & Delivery
| Selling Units: | Kilogram |
|---|
The file is encrypted. Please fill in the following information to continue accessing it